EPA Approves New Kill Claims for Veridien's Disinfectant Formula.

Business Editors/Health & Medical Writers

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Oct. 23, 2001

Next Generation Viraguard(R) Reduces Threat of Disease Transmission

Highlighted by Recent Bioterrorism Concerns;

Infection Control Team Working to Find Solutions

Veridien Corporation (OTCBB:VRDE) announced today that they have received Environmental Protection Administration (EPA) approval for the next generation liquid disinfectant in their Viraguard(R) product line. Viraguard(R) Hospital Disinfectant/Cleaner and Instrument Presoak completely eradicates eight categories of bacteria, including Staphylococcus aureus, Streptococcus pyogenes, Salmonella choleraesuis, Pseudomonas aeruginosa, and deadly E-coli that has caused numerous deaths associated with food contamination. EPA also now recognizes the product as effective against mutated bacterial strains, including Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus faecium (VRE). The EPA approval also recognizes the ability to kill Mycobacterium tuberculosis (TB), an encapsulated and harder to kill bacterial form. Effectiveness against these resistant strains is of particular importance to hospital and allied health professionals who insist on those claims being included on any product they purchase for surface disinfection. The EPA approval also recognizes the effectiveness of Viraguard(R) on seven virus categories including, but not limited to, HIV, Herpes, and Influenza, as well as effectiveness against the most common source of fungus infection.

Sheldon Fenton, President and CEO of Veridien Corp. stated, "Our commitment to bringing safe and effective disinfectant and antimicrobial products to the marketplace compels us to continue our research and development program towards finding new solutions to the natural and man made environmental challenges we face." Mr. Fenton continued, "With the current threat of bioterrorism, and Veridien's decade long track record of confronting infection control challenges, we will utilize all our expertise and resources to help safeguard workplaces and homes."

Viraguard(R) is approved for use on hard non-porous surfaces as a disinfectant and deodorizer for hospitals, clinics, medical offices, nursing homes, ambulances, hotels, restaurants, schools, health spas, and rest room facilities. Viraguard(R) leaves no harmful residue on the surfaces that it cleans and disinfects. Residue from other products is associated with the development of so-called "Superbugs" that are similar to the mutated resistant strains of bacteria that Viraguard(R) is proven to kill. The Viraguard(R) formulation is also available in a convenient towelette canister.

Viraguard(R) is the only hard surface disinfectant formula that is also registered with the U.S. Food and Drug Administration for use as an antimicrobial skin cleanser, available as a liquid spray, towelette, and clear hand gel.

Approval has also been granted by the Canadian Ministry of Health (Health Canada) for the use of the new Viraguard(R) in institutional medical settings and in the home as an antiseptic skin cleanser (Drug Identification Number issued) and as hard surface disinfectant (PCP Number issued).

Veridien has convened a panel of experts to expedite the review of the findings and implications of ongoing tests of various Viraguard(R) existing and developmental formulations including effectiveness against Bacillus anthracis, the bacteria that causes Anthrax, and against the family of bacillus associated with the transmission of Small Pox. Veridien's infection control team is focusing on possible solutions to deal with recent events of national concern.

About Veridien Corporation

Veridien Corporation is a Health Care Company focusing on Infection Control and other Healthy Lifestyle products. Veridien has developed patented and unique products including surface disinfectants, antiseptic hand gels, a multi-use skin and surface cleanser, contact lens care, and sun protectant products. The flagship product Viraguard(R) Hospital Disinfectant/Cleaner and Instrument Presoak is a patented, EPA registered, surface disinfectant, environmentally friendly and nontoxic by OSHA Standard 29 CFR 1910.1200. Viraguard(R) Antiseptic Hand Gel is an FDA drug listed product utilizing a patented Veridien formulation. Veridien's product lines are currently sold internationally through a variety of well-known distributors representing Medical, Dental, Food, Retail and Specialty markets. Veridien's products are also available under private label. Veridien is currently expanding sales to nationally and regionally known retail market chains and have expanded sales through E-Commerce.

Look for Veridien at: http://www.vrde.com; and The SunSwipe Corporation L.L.C. at: http://www.sun-swipe.com

Special Note: Forward-looking statements in this press release are made pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, market acceptance of, and demand for, the Company's products, manufacturing, development and distributor issues, product pricing, competition, technological changes and other risks not identified herein. The Company disclaims any intent or obligation to update any forward-looking statements.

"HEALTHY LIVING IS AN ADVENTURE - LET VERIDIEN GUIDE YOU"